---
figid: PMC7892797__gr3
figlink: pmc/articles/PMC7892797/figure/fig0003/
number: F3
caption: 'Schematic illustrating the role of the PLA2/COX cascade in the pathogenesis
  of schizophrenia and blunting of the niacin flush response. The PLA2/COX pathway
  is significantly disrupted in patients with schizophrenia: the level of cPLA2, which
  primarily mediates the dissociation of AA, is significantly increased, and catabolism
  of free AA is enhanced by COX-1. The metabolites affect nervous system function
  by interfering with the release of neurotransmitters and inducing overexpression
  of cytokines such as IL-6. However, downregulation of CREB1 and COX-2, as well as
  the decrease in the level of the PGE2 receptor EP4, may be related to the blunting
  of the niacin skin flush response.'
pmcid: PMC7892797
papertitle: Dysregulation of phospholipase and cyclooxygenase expression is involved
  in Schizophrenia.
reftext: Xuhan Yang, et al. EBioMedicine. 2021 Feb;64:103239.
pmc_ranked_result_index: '60541'
pathway_score: 0.9375136
filename: gr3.jpg
figtitle: Schematic illustrating the role of the PLA2/COX cascade in the pathogenesis
  of schizophrenia and blunting of the niacin flush response
year: '2021'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7892797__gr3.html
  '@type': Dataset
  description: 'Schematic illustrating the role of the PLA2/COX cascade in the pathogenesis
    of schizophrenia and blunting of the niacin flush response. The PLA2/COX pathway
    is significantly disrupted in patients with schizophrenia: the level of cPLA2,
    which primarily mediates the dissociation of AA, is significantly increased, and
    catabolism of free AA is enhanced by COX-1. The metabolites affect nervous system
    function by interfering with the release of neurotransmitters and inducing overexpression
    of cytokines such as IL-6. However, downregulation of CREB1 and COX-2, as well
    as the decrease in the level of the PGE2 receptor EP4, may be related to the blunting
    of the niacin skin flush response.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HCAR2
  - PLA2G1B
  - PLA2G2A
  - PLA2G5
  - PLA2G10
  - PLA2G2D
  - PLA2G2E
  - PLA2G3
  - PLA2G2F
  - PLA2G12A
  - PLA2G4D
  - PLA2G2C
  - PLA2G4A
  - PLA2G7
  - PLA2G6
  - PLA2G4C
  - PLA2G12B
  - ATF2
  - CREB5
  - CREB3
  - CREB3L3
  - ATF1
  - CREB1
  - CREM
  - CREB3L2
  - CREB3L1
  - CREB3L4
  - IL6
  - AP1S2
  - PTGER4
  - Niacin
  - PGG2
  - PGE2
  - TXA2
  - schizophrenia
  - skin flushing bluntness
genes:
- word: HCAR2
  symbol: HCAR2
  source: hgnc_symbol
  hgnc_symbol: HCAR2
  entrez: '338442'
- word: –ùCAR2
  symbol: HCAR2
  source: hgnc_symbol
  hgnc_symbol: HCAR2
  entrez: '338442'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G1B
  entrez: '5319'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2A
  entrez: '5320'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G5
  entrez: '5322'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G10
  entrez: '8399'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2D
  entrez: '26279'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2E
  entrez: '30814'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G3
  entrez: '50487'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2F
  entrez: '64600'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12A
  entrez: '81579'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4D
  entrez: '283748'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2C
  entrez: '391013'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4A
  entrez: '5321'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G7
  entrez: '7941'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G6
  entrez: '8398'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4C
  entrez: '8605'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12B
  entrez: '84647'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: PGs,TXA2
  symbol: PGS
  source: hgnc_prev_symbol
  hgnc_symbol: AP1S2
  entrez: '8905'
- word: EP4
  symbol: EP4
  source: hgnc_alias_symbol
  hgnc_symbol: PTGER4
  entrez: '5734'
chemicals:
- word: Niacin
  source: MESH
  identifier: D009525
- word: PGG2
  source: MESH
  identifier: C038291
- word: PGE2
  source: MESH
  identifier: D015232
- word: TXA2
  source: MESH
  identifier: D014148
diseases:
- word: schizophrenia
  source: MESH
  identifier: D012559
- word: skin flushing bluntness
  source: MESH
  identifier: D005483
figid_alias: PMC7892797__F3
redirect_from: /figures/PMC7892797__F3
figtype: Figure
---
